Telling Alzheimer's apart from late-life depression on a brain scan

In an older adult, the early signs can be maddeningly similar. Memory slips, withdrawal, a flatness of mood, trouble concentrating. Is it the start of Alzheimer's disease, or is it late-life depression? Getting that answer right matters enormously, because the two go in almost opposite directions when it comes to treatment. A new imaging study suggests the brain may carry signatures that help tell them apart.

The research, published in the Journal of Affective Disorders by a team at the Affiliated Psychiatric Hospital of Anhui Medical University in China, compared three groups of older, right-handed adults: 33 with Alzheimer's, 38 with late-life depression, and 40 healthy controls [1]. Everyone had high-resolution structural MRI scans, which the researchers then overlaid against databases of neurotransmitter systems and cell types. The idea was to move past "where is the brain different" toward "what kind of difference is this."

Two very different fingerprints

Alzheimer's showed up as loss [1]. The scans revealed shrinkage in the hippocampus, the cingulate cortex, and the precuneus, with broader thinning spreading across the temporal, parietal, frontal, and occipital lobes. Layered onto that were reductions in cholinergic and dopaminergic receptor systems, chemistry that tracks with the disease's known biology.

Late-life depression looked nothing like that. There was no significant loss of brain volume compared with healthy controls. Instead the differences were chemical and functional: altered dopamine and serotonin transporters, increased NMDA receptor signaling, and reduced blood flow in parts of the brain. In other words, the depressed brain in these patients was not visibly wasting away. It was running differently. That distinction between tissue loss and functional change in the same organ matters across neuroscience — it closely mirrors what large-scale MRI studies find when tracking how the thalamus and amygdala gradually shrink in long-term shift workers.

One contrast stood out. A type of inhibitory cell called the PVALB interneuron appeared to be lost in depression but clustered in Alzheimer's, hinting at early overexcitability in the Alzheimer's group. The two conditions were not simply mild and severe versions of the same decline. They were distinct processes that happen to wave at each other across a waiting room.

The groups did share a little common ground, including disruptions in serotonin systems and in the mitochondria that power cells. That overlap may explain why the surface symptoms can blur together even when the underlying biology diverges.

Why this could matter in the clinic

If these patterns hold up, they point toward earlier and more confident differentiation. That is not academic. An older adult misdiagnosed with depression when the real process is Alzheimer's loses time on the wrong plan, and the reverse mistake can saddle a treatable depression with a frightening, incorrect label. A scan-based signal that nudges clinicians toward the right answer sooner has real human stakes.

The limits to keep in view

This was a modest sample, around a hundred people across three groups, and the control scans came from different equipment, which the team corrected for statistically but could not erase entirely. The overlay approach also shows correlation between brain regions and known chemical maps; it does not measure each individual's neurochemistry directly. So this is a promising map, not a diagnostic test you could order tomorrow.

What it adds is a clearer picture of two conditions that have long been hard to separate when they first appear. Alzheimer's tends to take tissue. Late-life depression tends to change how the tissue works. Seeing that difference on a scan, reliably and early, would be a genuinely useful thing to have. For more neuroscience coverage, see the full category.

Sources

1. Yang, S., Wang, X., Yan, Y., Zhang, J., Wei, Y., Zhang, D., & Yao, W. (2025). Gray matter structural and molecular signatures in Alzheimer's disease and late-life depression. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120915

This article summarizes published research for general informational purposes only. It is not medical advice and should not be used to guide treatment, diagnosis, or other health decisions. Speak with a qualified healthcare professional about any health concern.